Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings]

Br J Clin Pharmacol. 1979 Oct;8(4):403P-404P.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / blood
  • Adrenergic beta-Antagonists / pharmacology*
  • Hemodynamics / drug effects*
  • Humans
  • Injections, Intravenous
  • Male
  • Propanolamines / administration & dosage
  • Propanolamines / blood
  • Propanolamines / pharmacology*

Substances

  • Adrenergic beta-Antagonists
  • Propanolamines